IDEX Acquires ThinXXS To Boost Scientific Fluidics Business
Zacks Investment Research | Dec 11, 2017 08:32PM ET
Industrial goods manufacturer IDEX Corporation (NYSE:IEX) recently inked a definitive agreement to acquire German firm — thinXXS Microtechnology AG — for an undisclosed amount. Post acquisition, thinXXS will form an integral part of the Health and Science Technologies segment of IDEX and will strengthen its presence in the global life science and veterinary markets with world-class products and solutions.
Located in Zweibrücken, Germany, thinXXS is a premier manufacturer of disposable microfluidic components for the point of care, veterinary and life science markets. It also develops various customer-specific solutions for applications in immunology, clinical chemistry, DNA analytic or cell-based research.
The acquisition is a strategic fit for IDEX’s core optics and scientific fluidics product portfolio that serves life science customers. The deal is the second of its kind in this space and strengthens the market position of the company as an undisputed leader in microfluidic technology.
Acquisitions have been IDEX’s most favored mode for penetrating unexplored markets, which extend its geographic reach, fill technology gaps and strengthen its foothold in the existing markets while expanding product lines.
At the same time, IDEX is striving to expand its businesses in the emerging markets by focusing on organic growth. The company reported organic growth of 7% in the third quarter of 2017 owing to a diligent execution of operational plans. IDEX aims to increase its market exposure and improve sales mix by continually developing new products. With a flexible yet disciplined focus on cost and productivity and a holistic growth model, IDEX has outperformed the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.